IL-1β, IL-6, KC and MCP-1 are elevated in synovial fluid from haemophilic mice with experimentally induced haemarthrosis

Haemophilia

Volumn 15, Issue 3, 2009, Pages 802-810

  Øvlisen, Kirstine ^a   Kristensen, A T ^b   Jensen, A L ^b   Tranholm, M ^a  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cytokines; Haemophilia A; Joint bleeds; Murine model; Synovial fluid

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NN 1731; RANTES; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 7A DERIVATIVE; RECOMBINANT BLOOD CLOTTING FACTOR 8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG MEGADOSE; HEMARTHROSIS; HEMOPHILIA A; INFLAMMATION; KNEE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCORING SYSTEM; SYNOVIAL FLUID;

ANIMALS; CHEMOKINE CCL2; FACTOR VIIA; FACTOR VIII; HEMARTHROSIS; HEMOPHILIA A; INTERLEUKIN-1BETA; INTERLEUKIN-6; JOINTS; MICE; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; SYNOVIAL FLUID;

EID: 65449121410     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01973.x     Document Type: Article

References (48)

1. Ahlberg A. Treatment and prophylaxis of arthropathy in severe hemophilia. Clin Orthop Relat Res 1967; 53: 135-46.
2. Madhok R, York J, Sturrock RD. Haemophilic arthritis. Ann Rheum Dis 1991; 50: 588-91.
3. Roosendaal G, Lafeber FP. Blood-induced joint damage in hemophilia. Semin Thromb Hemost 2003; 29: 37-42.
4. Rodriguez-Merchan EC. Common orthopaedic problems in haemophilia. Haemophilia 1999; 5: 53-60.
5. Roosendaal G, Mauser-Bunschoten EP, De KP et al. Synovium in haemophilic arthropathy. Haemophilia 1998; 4: 502-5.
6. Rodriguez-Merchan EC. Haemophilic synovitis: Basic concepts. Haemophilia 2007; 13: 1-3.
7. Roy S, Ghadially FN. Pathology of experimental haemarthrosis. Ann Rheum Dis 1966; 25: 402-15.
8. Mainardi CL, Levine PH, Werb Z, Harris ED Jr. Proliferative synovitis in hemophilia: Biochemical and morphologic observations. Arthritis Rheum 1978; 21: 137-44.
9. Rodriguez-Merchan EC. The destructive capabilities of the synovium in the haemophilic joint. Haemophilia 1998; 4: 506-10.
10. Arnold WD, Hilgartner MW. Hemophilic arthropathy. Current concepts of pathogenesis and management. J Bone Joint Surg Am 1977; 59: 287-305.
11. Brackmann HH, Eickhoff HJ, Oldenburg J, Hammerstein U. Long-term therapy and on-demand treatment of children and adolescents with severe hemophilia-A -12years of experience. Haemostasis 1992; 22: 251-8.
12. Roosendaal G, Vianen ME, Van Den Berg HM, Lafeber FP, Bijlsma JW. Cartilage damage as a result of hemarthrosis in a human in vitro model. J Rheumatol 1997; 24: 1350-4.
13. Valentino LA, Hakobyan N, Rodriguez N, Hoots WK. Pathogenesis of haemophilic synovitis: Experimental studies on blood-induced joint damage. Haemophilia 2007; 13: 10-3.
14. Tagariello G, Traldi A, Davoli PG et al. May interleukin-1 in synovial tissue play a major role in the progression of haemophilic arthropathy? Proceedings of the 4th Musculoskeletal Congress of the World Federation of Haemophilia 1997; 21.
15. Hooiveld M, Roosendaal G, Wenting M, van den Berg M, Bijlsma J, Lafeber F. Short-term exposure of cartilage to blood results in chondrocyte apoptosis. Am J Pathol 2003; 162: 943-51.
16. Hooiveld MJ, Roosendaal G, Van Den Berg HM, Bijlsma JW, Lafeber FP. Haemoglobin-derived iron-dependent hydroxyl radical formation in blood-induced joint damage: An in vitro study. Rheumatology (Oxford) 2003; 42: 784-90.
17. Roosendaal G, Vianen ME, Wenting MJ et al. Iron deposits and catabolic properties of synovial tissue from patients with haemophilia. J Bone Joint Surg Br 1998; 80: 540-5.
18. Roosendaal G, Vianen ME, Marx JJ, Van Den Berg HM, Lafeber FP, Bijlsma JW. Blood-induced joint damage: A human in vitro study. Arthritis Rheum 1999; 42: 1025-32.
19. Øvlisen K, Kristensen AT, Valentino LA, Hakobyan N, Ingerslev J, Tranholm M. Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice. J Thromb Haemost 2008; 6: 969-75.
20. Valentino LA, Hakobyan N, Kazarian T, Jabbar KJ, Jabbar AA. Experimental haemophilic synovitis: Rationale and development of a murine model of human factor VIII deficiency. Haemophilia 2004; 10: 280-7.
21. Skogstrand K, Thorsen P, Norgaard-Pedersen B, Schendel DE, Sorensen LC, Hougaard DM. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 2005; 51: 1854-66.
22. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436-45.
23. Bozic CR, Gerard NP, von Uexkull-Guldenband C et al. The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. J Biol Chem 1994; 269: 29355-8.
24. Conti P, Reale M, Barbacane RC, Castellani ML, Orso C. Differential production of RANTES and MCP-1 in synovial fluid from the inflamed human knee. Immunol Lett 2002; 80: 105-11.
25. Fujita Y, Hara Y, Nezu Y, Schulz KS, Tagawa M. Proinflammatory cytokine activities, matrix metalloproteinase-3 activity, and sulfated glycosaminoglycan content in synovial fluid of dogs with naturally acquired cranial cruciate ligament rupture. Vet Surg 2006; 35: 369-76.
26. Guerne PA, Carson DA, Lotz M. IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol 1990; 144: 499-505.
27. Lubberts E, Joosten LAB, Oppers B et al. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol 2001; 167: 1004-13.
28. Roosendaal G, van Rinsum AC, Vianen ME, Van Den Berg HM, Lafeber FP, Bijlsma JW. Haemophilic arthropathy resembles degenerative rather than inflammatory joint disease. Histopathology 1999; 34: 144-53.
29. Goldring MB. The role of cytokines as inflammatory mediators in osteoarthritis: Lessons from animal models. Connect Tissue Res 1999; 40: 1-11.
30. van Den Berg WB. Uncoupling of inflammatory and destructive mechanisms in arthritis. Semin Arthritis Rheum 2001;30 (5 Suppl. 2): 7-16.
31. Harigai M, Hara M, Yoshimura T, Leonard EJ, Inoue K, Kashiwazaki S. Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium. Clin Immunol Immunopathol 1993; 69: 83-91.
32. Lubberts E, Joosten LAB, Helsen MMA, van den Berg WB. Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (scw) arthritis. more therapeutic benefit with il-4/il-10 combination therapy than with il-10 treatment alone. Cytokine 1998; 10: 361-9.
33. de Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003; 10: 133-9.
34. Tranholm M, Kristensen K, Kristensen AT, Pyke C, Rojkjaer R, Persson E. Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A. Blood 2003; 102: 3615-20.
35. Ghosh S, Ezban M, Persson E, Pendurthi U, Hedner U, Rao LVM. Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface. J Thromb Haemost 2007; 5: 336-46.
36. Lubberts E, Joosten LAB, van den Bersselaar L et al. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. J Immunol 1999; 163: 4546-56.
37. Chabaud M, Lubberts E, Joosten L, van Den BW, Miossec P. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res 2001; 3: 168-77.
38. van den Berg WB. Lessons from animal models of arthritis. Curr Rheumatol Rep 2002; 4: 232-9.
39. Goldring MB. Anticytokine therapy for osteoarthritis. Expert Opin Biol Ther 2001; 1: 817-29.
40. Cai L, Yin JP, Starovasnik MA et al. Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo. Cytokine 2001; 16: 10-21.
41. Raza K, Falciani F, Curnow SJ et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 2005; 7: R784-95.
42. Silverman ED, Isacovics B, Petsche D, Laxer RM. Synovial fluid cells in juvenile arthritis: Evidence of selective T cell migration to inflamed tissue. Clin Exp Immunol 1993; 91: 90-5.
43. Wedderburn LR. Tracking T cells in arthritis. Rheumatology 2000; 39: 458-62.
44. Stanczyk J, Kowalski ML, Grzegorczyk J et al. RANTES and chemotactic activity in synovial fluids from patients with rheumatoid arthritis and osteoarthritis. Mediators Inflamm 2005 2005; 6: 343-8.
45. Lu B, Rutledge BJ, Gu L et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 1998; 187: 601-8.
46. Walker JS, Chandler AK, Wilson JL, Binder W, Day RO. Effect of mu-opioids morphine and buprenorphine on the development of adjuvant arthritis in rats. Inflamm Res 1996; 45: 557-63.
47. van den Berg W. Anti-cytokine therapy in chronic destructive arthritis. Arthritis Res 2001;3: 18-26.
48. Jansen NW, Roosendaal G, Hooiveld MJ et al. Interleukin-10 protects against blood-induced joint damage. Br J Haematol 2008; 142: 953-61.